Showing results (3041-3050 of 4,142) with videos related to
Sort By:
Pageof 415
Molecular Carcinogenesis|October 11, 2023
FOXK1 upregulation is correlated with tumor progression and tumor associated macrophages infiltration in renal cell carcinomaShaojun Chen, Xiuwu Pan, Liang Zhang, et al.Molecular Carcinogenesis|July 4, 2023
Mitochondria-targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen speciesMohammad Shameem, Alireza Jian Bagherpoor, Ali Nakhi, et al.Molecular Carcinogenesis|July 26, 2023
USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinomaDewang Fu, Qingyue Si, Chenxi Yu, et al.Molecular Carcinogenesis|August 29, 2023
Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancerQiuyang Chen, Yue Fu, Xinchun Liu, et al.Molecular Carcinogenesis|June 14, 2023
A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancerXun Li, Yu Zhang, Yang Li, et al.Molecular Carcinogenesis|October 4, 2023
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasisXiaocong Xiang, Wei Kuang, Chunlei Yu, et al.Molecular Carcinogenesis|October 3, 2023
Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1Wei Hou, Shaimaa A Gad, Xianzhong Ding, et al.Molecular Carcinogenesis|September 22, 2023
CDK10 suppresses metastasis of lung adenocarcinoma through inhibition of the ETS2/c-Raf/p-MEK/p-ERK signaling loopXiujuan Zhang, Yu Zhao, Ruzetuoheti Yiminniyaze, et al.Molecular Carcinogenesis|October 3, 2023
A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cellsAli Tafti, Samaneh Shojaei, Hakimeh Zali, et al.Molecular Carcinogenesis|October 3, 2023
A genetic variant in gene NDUFAF4 confers the risk of non-small cell lung cancer by perturbing hsa-miR-215 bindingTingting Long, Jiaoyuan Li, Tongxin Yin, et al.Pageof 415